Pre-exposure prophylaxis (PrEP) with TDF/FTC significantly reduces the risk for HIV-1 transmission, but, to date, nobody knows if PrEP can still be useful in case of viruses harboring resistances to TDF/FTC or if alternative antiretroviral drugs might be rather proposed in selected cases. We promote the debate by describing a case of an acute infection with multiresistant HIV that occurred in a young girl who started a relationship with an HIV-infected partner who had a known multiresistant HIV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/AID.2017.0112 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!